ctrl K

Watchlist Price Alert

Scopus BioPharma Inc. (SCPS)

OTC: SCPS · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Mar 24, 2025, 11:51 AM

Scopus BioPharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a
Operating Income	-11.71M	-27.63M	-10.16M	-2.69M	-685.96K
Interest Income	n/a	n/a	n/a	n/a	n/a
Pretax Income	-11.71M	-26.95M	-10.86M	-2.69M	-685.96K
Net Income	-11.61M	-27.73M	-11.57M	-2.69M	-685.96K
Selling & General & Admin	9.03M	12.61M	2.73M	2.23M	408.43K
Research & Development	2.68M	15.02M	7.42M	463.11K	277.54K
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	11.71M	27.63M	10.16M	2.69M	685.96K
Interest Expense	n/a	774.68K	706.45K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	11.71M	27.63M	10.16M	2.69M	685.96K
Income Tax Expense	-105.05K	774.68K	706.45K	1.00	-847.11K
Shares Outstanding (Basic)	21.09M	17.25M	13.36M	14.98M	14.98M
Shares Outstanding (Diluted)	21.09M	17.25M	13.36M	14.98M	14.98M
EPS (Basic)	-0.55	-1.61	-0.87	-0.18	-0.05
EPS (Diluted)	-0.55	-1.61	-0.87	-0.18	-0.05
EBITDA	-11.71M	-27.63M	-10.15M	-2.69M	-685.96K
EBIT	n/a	-26.18M	n/a	n/a	n/a
Depreciation & Amortization	1.73K	1.5K	1.44K	664.00	161.14K